These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17294608)

  • 1. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.
    Parmenter BA; Denney DR; Lynch SG; Middleton LS; Harlan LM
    Mult Scler; 2007 Jan; 13(1):25-32. PubMed ID: 17294608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
    van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
    Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
    Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
    Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.
    Savettieri G; Messina D; Andreoli V; Bonavita S; Caltagirone C; Cittadella R; Farina D; Fazio MC; Girlanda P; Le Pira F; Liguori M; Lugaresi A; Nocentini U; Reggio A; Salemi G; Tedeschi G; Trojano M; Valentino P; Quattrone A
    J Neurol; 2004 Oct; 251(10):1208-14. PubMed ID: 15503099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE epsilon4 and the cognitive genetics of multiple sclerosis.
    Ghaffar O; Reis M; Pennell N; O'Connor P; Feinstein A
    Neurology; 2010 May; 74(20):1611-8. PubMed ID: 20479360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE and risk of cognitive impairment in multiple sclerosis.
    Oliveri RL; Cittadella R; Sibilia G; Manna I; Valentino P; Gambardella A; Aguglia U; Zappia M; Romeo N; Andreoli V; Bono F; Caracciolo M; Quattrone A
    Acta Neurol Scand; 1999 Nov; 100(5):290-5. PubMed ID: 10536914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
    Tamam Y; Tasdemir N; Yalman M; Tamam B
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between ApoE epsilon4 and cognitive impairment after stroke.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
    Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
    J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects.
    Norberg J; Graff C; Almkvist O; Ewers M; Frisoni GB; Frölich L; Hampel H; Jones RW; Kehoe PG; Lenoir H; Minthon L; Nobili F; Olde Rikkert M; Rigaud AS; Scheltens P; Soininen H; Spiru L; Tsolaki M; Wahlund LO; Vellas B; Wilcock G; Elias-Sonnenschein LS; Verhey FR; Visser PJ
    Dement Geriatr Cogn Disord; 2011; 32(2):135-42. PubMed ID: 21952537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E polymorphism carriers exhibit objective cognitive deficits: a single center trial.
    Zeng Y; Huang X; Elkin K; Stone C; Rajah GB; Guan L; Du H; Geng X
    Neurol Res; 2020 Aug; 42(8):676-682. PubMed ID: 32634047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
    Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of APOE polymorphisms with disease severity in MS is limited to women.
    Kantarci OH; Hebrink DD; Achenbach SJ; Pittock SJ; Altintas A; Schaefer-Klein JL; Atkinson EJ; De Andrade M; McMurray CT; Rodriguez M; Weinshenker BG
    Neurology; 2004 Mar; 62(5):811-4. PubMed ID: 15007140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.